A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
Gabapentin — The Popular but Controversial Anticonvulsant Drug May Be Zeroing in on the Pathophysiology of Disease
2021
American Journal of Clinical and Experimental Medicine
Originally marketed under the brand name Neurontin, the anticonvulsant drug gabapentin has become one of the most widely prescribed-and one of the most controversial-drugs in America. On the market for nearly three decades, the drug has been prescribed for everything from chronic cough to chronic pain and hot flashes to bipolar disorder; but is it the real deal, or is it just the brain-child of aggressive marketing, false advertising, and wishful thinking? This critical review will dissect
doi:10.11648/j.ajcem.20210904.15
fatcat:jyjsxvpvpbg5rlrumlymyzu5bq